BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211119T140000
DTEND;TZID=America/New_York:20211119T150000
DTSTAMP:20260525T044158
CREATED:20211026T161854Z
LAST-MODIFIED:20211026T161854Z
UID:5639-1637330400-1637334000@carb-x.org
SUMMARY:McGill AMR Innovation Summit
DESCRIPTION:Antimicrobials in the era of AMR\nDuring World Antimicrobial Awareness Week (Nov. 18-24 2021)\, the McGill AMR Centre and Innovation + Partnership office are hosting the inaugural McGill AMR Innovation Summit\, a virtual event aimed at discussing antimicrobial R&D and building collaborations and partnerships between McGill scientists and non-academic stakeholders. \nProgram\n\n14:00-14:30 Keynote speaker Erin Duffy\, PhD (public event)\n14:30-15:00 Panel discussion (public event)\n15:00-16:00 Industry-Academic networking event (private event)\n\nKeynote speaker Erin Duffy\, PhD\, Chief of R&D\, CARB-X\nCARB-X is a global non-profit partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria. With up to US$480 million to invest in 2016-22\, CARB-X portfolio is the world’s largest early development pipeline in AMR. \nPanel discussion Challenges and opportunities for antimicrobial R&D in the era of AMR\nWith experts from industry and academia. \n• David Claveau\, PhD\, Director\, Medical Affairs at AVIR Pharma\n• Erin Duffy\, PhD\, Chief of Research & Development\, CARB-X\n• Joseph Mancini\, PhD\, Head of Pharmacology and Biologics\, Senior Director at adMare BioInnovations\n• Nicolas Moitessier\, PhD\, Professor in Chemistry (McGill)\, co-founder of Molecular Forecaster\n• Martin Schmeing\, PhD\, Professor in Biochemistry (McGill)\, Director of Centre for Structural Biology\n• Christopher Tan\, PhD\, Director\, Business Development & Licensing\, Search & Evaluation\, Infectious Diseases & Vaccines at Merck Research Laboratories \nRegistration is free but required. \nIf you have any questions\, please contact us at amrcentre@mcgill.ca \nClick here to learn more.\nClick here to register.
URL:https://carb-x.org/event/mcgill-amr-innovation-summit/
LOCATION:VIRTUAL EVENT
ORGANIZER;CN="McGill University":MAILTO:amrcentre@mgcill.ca
END:VEVENT
END:VCALENDAR